Home > Boards > US OTC > Biotechs > Inari Medical, Inc. (NARI)

Inari Medical, Inc. is a commercial-stage medical device

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
crudeoil24 Member Profile
Member Level 
Followed By 721
Posts 48,373
Boards Moderated 31
Alias Born 12/12/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/17/2021 6:41:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2021 5:11:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2021 5:11:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/9/2021 4:36:50 PM
Inari Medical EPS beats by $0.01, beats on revenue Seeking Alpha - 11/9/2021 4:16:45 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:10:20 PM
Inari Medical Reports Third Quarter 2021 Financial Results GlobeNewswire Inc. - 11/9/2021 4:01:00 PM
Inari Medical Q3 2021 Earnings Preview Seeking Alpha - 11/8/2021 5:35:18 PM
Inari Medical's FlowTriever device benefits patients with pulmonary embolism in study Seeking Alpha - 10/28/2021 8:52:07 AM
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombectomy in 500 Real-World PE Patients GlobeNewswire Inc. - 10/28/2021 8:01:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/27/2021 4:57:26 PM
Inari Medical to Announce Third Quarter 2021 Financial Results GlobeNewswire Inc. - 10/26/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/21/2021 5:55:33 PM
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmonary Embolism Patients GlobeNewswire Inc. - 10/18/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/12/2021 4:50:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/12/2021 4:49:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/6/2021 5:49:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/5/2021 6:00:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/4/2021 6:29:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/4/2021 6:29:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/4/2021 5:20:39 PM
Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors GlobeNewswire Inc. - 10/1/2021 8:00:00 AM
Inari Medical Appoints Pulmonologist Dr. Victor F. Tapson as VP of Medical Affairs GlobeNewswire Inc. - 9/21/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/10/2021 6:58:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 3:07:46 PM
crudeoil24 Member Level  Friday, 05/22/20 12:49:00 PM
Re: None
Post # of 51 
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.

Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.

New York Yankees and Duke Basketball
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences